In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

An experimental once-weekly insulin known as efsitora has shown comparable effectiveness to daily insulin regimens in ...

This work provides a multidimensional method for the simultaneous, direct quantification of intact human insulin and five insulin analogs in human plasma. This investigation solves both the ...

Insulin lispro has a very rapid action, with a peak 1 h after subcutaneous injection, and a duration of 2-4 h. [49] ...

Notably, GZR4 injection achieved superior HbA1c reduction in patients with inadequate glycemic control on prior basal insulin therapy compared to once-daily insulin degludec (Tresiba®).

Currently, Gan & Lee has six core insulin products, including five insulin analog varieties: long-acting glargine injection (Basalin ®), fast-acting lispro injection (Prandilin™), fast-acting ...

Figure 1. Pathways linking local obesity-induced inflammation to systemic insulin resistance. Obesity results in the activation of the inflammatory signaling pathways mediated by JNK and nuclear ...

CLEVELAND, OH, UNITED STATES, June 19, 2025 / EINPresswire.com / -- Diasome Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company advancing portal-hepatic targeted therapies for metabolic ...

Ultrasound can be used to detect early-developing insulin resistance in adults with obesity, according to a study published June 12 in the Journal of Ultrasound Medicine. Here are three things to ...

FDA approves Yeztugo as the first U.S. twice-yearly injectable for HIV prevention, showing 99.9% efficacy and broad access for all patients.